Clinical Trials Using Ilorasertib

Clinical trials are research studies that involve people. The clinical trials on this list are studying Ilorasertib. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Ilorasertib in Treating Patients with CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

    This pilot phase I trial studies how well ilorasertib works in treating patients with cyclin-dependent kinase inhibitor 2A (CDKN2A)-deficient solid cancers that have spread to other places in the body and usually cannot be cured or controlled with treatment (advanced) or have spread to other places in the body (metastatic) and cannot be removed by surgery. Ilorasertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
    Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois